Status: Recruiting
Taiwan Associated Genetic and Nongenetic Small Vessel Disease
The TAG-SVD enrolled patients with clinical and neuroimaging features of cerebral small vessel disease (CSVD). All enrolled patients will receive next-generation sequence (NGS) with probes designed to target five candidate CSVD genes, and patients will be divided into genetic or non-genetic groups accordingly. Their clinical features and outcome will be followed for at least 2 years.
Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: National Taiwan University HospitalUpdated: Jan 20, 2026Locations: 1Duration: 2 Years
Eligibility criteria
stroke (especially small vessel occlusion type of ischaemic stroke, spontaneous... [+6]
MRI evidence of CSVD due to other inflammatory, malignancy, or structural lesion... [+1]